BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 21778670)

  • 1. Utility of multidetector row CT in diagnosing branch duct IPMNs of the pancreas compared with MR cholangiopancreatography and endoscopic ultrasonography.
    Arikawa S; Uchida M; Uozumi J; Sakoda J; Kaida H; Kunou Y; Hirose Y; Abe T; Hayabuchi N; Naito Y; Okabe Y; Suga H; Kinoshita H
    Kurume Med J; 2011; 57(4):91-100. PubMed ID: 21778670
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The role of multi-detector-row computed tomograph in the diagnosis of intraductal papillary-mucinous tumors of the pancreas in comparison to endoscopic retrograde pancreatography, endoscopic ultrasonography, magnetic resonance cholangiopancreatography].
    Arikawa S; Uchida M; Shinagawa M; Uozumi J; Hayabuchi N; Okabe Y; Suga H; Yanagi K; Kinoshita H; Naitou Y
    Nihon Shokakibyo Gakkai Zasshi; 2007 Mar; 104(3):373-80. PubMed ID: 17337874
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intraductal papillary mucinous neoplasm of pancreas: multi-detector row CT with 2D curved reformations--correlation with MRCP.
    Sahani DV; Kadavigere R; Blake M; Fernandez-Del Castillo C; Lauwers GY; Hahn PF
    Radiology; 2006 Feb; 238(2):560-9. PubMed ID: 16436817
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of Malignant Potential in Intraductal Papillary Mucinous Neoplasms of the Pancreas: Comparison between Multidetector CT and MR Imaging with MR Cholangiopancreatography.
    Kang HJ; Lee JM; Joo I; Hur BY; Jeon JH; Jang JY; Lee K; Ryu JK; Han JK; Choi BI
    Radiology; 2016 Apr; 279(1):128-39. PubMed ID: 26517448
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Single-institution validation of the international consensus guidelines for treatment of branch duct intraductal papillary mucinous neoplasms of the pancreas.
    Nagai K; Doi R; Ito T; Kida A; Koizumi M; Masui T; Kawaguchi Y; Ogawa K; Uemoto S
    J Hepatobiliary Pancreat Surg; 2009; 16(3):353-8. PubMed ID: 19280108
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 18-fluorodeoxyglucose positron emission tomography enhances computed tomography diagnosis of malignant intraductal papillary mucinous neoplasms of the pancreas.
    Sperti C; Bissoli S; Pasquali C; Frison L; Liessi G; Chierichetti F; Pedrazzoli S
    Ann Surg; 2007 Dec; 246(6):932-7; discussion 937-9. PubMed ID: 18043094
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of ductal carcinoma of the pancreas during follow-up of branch duct intraductal papillary mucinous neoplasm of the pancreas.
    Uehara H; Nakaizumi A; Ishikawa O; Iishi H; Tatsumi K; Takakura R; Ishida T; Takano Y; Tanaka S; Takenaka A
    Gut; 2008 Nov; 57(11):1561-5. PubMed ID: 18477671
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Added value of diffusion-weighted imaging to MR cholangiopancreatography with unenhanced mr imaging for predicting malignancy or invasiveness of intraductal papillary mucinous neoplasm of the pancreas.
    Kang KM; Lee JM; Shin CI; Baek JH; Kim SH; Yoon JH; Han JK; Choi BI
    J Magn Reson Imaging; 2013 Sep; 38(3):555-63. PubMed ID: 23390008
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Main pancreatic duct intraductal papillary mucinous neoplasms: accuracy of MR imaging in differentiation between benign and malignant tumors compared with histopathologic analysis.
    Manfredi R; Graziani R; Motton M; Mantovani W; Baltieri S; Tognolini A; Crippa S; Capelli P; Salvia R; Pozzi Mucelli R
    Radiology; 2009 Oct; 253(1):106-15. PubMed ID: 19703865
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Another dimension in magnetic resonance cholangiopancreatography: comparison of 2- and 3-dimensional magnetic resonance cholangiopancreatography for the evaluation of intraductal papillary mucinous neoplasm of the pancreas.
    Yoon LS; Catalano OA; Fritz S; Ferrone CR; Hahn PF; Sahani DV
    J Comput Assist Tomogr; 2009; 33(3):363-8. PubMed ID: 19478628
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Appropriate indications of initial endoscopic ultrasound evaluation for detecting mural nodules in branch duct intraductal papillary mucinous neoplasms of the pancreas.
    Kim YI; Woo SM; Lee WJ; Han SS; Park SJ; Kim TH; Koh YH; Hong EK
    Scand J Gastroenterol; 2013 May; 48(5):610-6. PubMed ID: 23597152
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endoscopic ultrasonographic findings predict the risk of carcinoma in branch duct intraductal papillary mucinous neoplasms of the pancreas.
    Kobayashi N; Sugimori K; Shimamura T; Hosono K; Watanabe S; Kato S; Ueda M; Endo I; Inayama Y; Maeda S; Nakajima A; Kubota K
    Pancreatology; 2012; 12(2):141-5. PubMed ID: 22487524
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Imaging features to distinguish malignant and benign branch-duct type intraductal papillary mucinous neoplasms of the pancreas: a meta-analysis.
    Kim KW; Park SH; Pyo J; Yoon SH; Byun JH; Lee MG; Krajewski KM; Ramaiya NH
    Ann Surg; 2014 Jan; 259(1):72-81. PubMed ID: 23657084
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential diagnosis of benign or malignant intraductal papillary mucinous neoplasm of the pancreas by multidetector row helical computed tomography: evaluation of predictive factors by logistic regression analysis.
    Takeshita K; Kutomi K; Takada K; Haruyama T; Fukushima J; Aida R; Takada T; Furui S
    J Comput Assist Tomogr; 2008; 32(2):191-7. PubMed ID: 18379300
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of F-18 fluorodeoxyglucose positron emission tomography with dual-phase imaging to identify intraductal papillary mucinous neoplasm.
    Saito M; Ishihara T; Tada M; Tsuyuguchi T; Mikata R; Sakai Y; Tawada K; Sugiyama H; Kurosawa J; Otsuka M; Uchida Y; Uchiyama K; Miyazaki M; Yokosuka O
    Clin Gastroenterol Hepatol; 2013 Feb; 11(2):181-6. PubMed ID: 23142206
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical Feasibility of Abbreviated Magnetic Resonance With Breath-Hold 3-Dimensional Magnetic Resonance Cholangiopancreatography for Surveillance of Pancreatic Intraductal Papillary Mucinous Neoplasm.
    Kang HJ; Lee DH; Lee JM; Yoo J; Weiland E; Kim E; Son Y
    Invest Radiol; 2020 May; 55(5):262-269. PubMed ID: 32073419
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictors of malignancy in pure branch duct type intraductal papillary mucinous neoplasm of the pancreas: A nationwide multicenter study.
    Kim TH; Song TJ; Hwang JH; Yoo KS; Lee WJ; Lee KH; Dong SH; Park CH; Park ET; Moon JH; Kim HG; Kim EY; Cho KB; Kim HJ; Lee SO; Cheon YK; Lee JM; Oh DW; Kim MH
    Pancreatology; 2015; 15(4):405-10. PubMed ID: 25998516
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distinguishing benign from malignant intraductal papillary mucinous tumors of the pancreas by imaging techniques.
    Baba T; Yamaguchi T; Ishihara T; Kobayashi A; Oshima T; Sakaue N; Kato K; Ebara M; Saisho H
    Pancreas; 2004 Oct; 29(3):212-7. PubMed ID: 15367887
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Imaging features of intraductal papillary mucinous neoplasms of the pancreas in multi-detector row computed tomography.
    Tan L; Zhao YE; Wang DB; Wang QB; Hu J; Chen KM; Deng XX
    World J Gastroenterol; 2009 Aug; 15(32):4037-43. PubMed ID: 19705500
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Approach to cystic lesions of the pancreas.
    Schmid RM; Siveke JT
    Wien Med Wochenschr; 2014 Feb; 164(3-4):44-50. PubMed ID: 24254128
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.